Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
RELMADA THERAPEUTICS, INC. | Chief Financial Officer | Common Stock | 88.3K | $261K | $2.95 | Sep 11, 2024 | Direct |
RELMADA THERAPEUTICS, INC. | Chief Financial Officer | Stock Option (right to buy) | 82.1K | May 24, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
RLMD | RELMADA THERAPEUTICS, INC. | Sep 9, 2024 | 3 | $150K | 4 | Sep 11, 2024 | Chief Financial Officer |
RLMD | RELMADA THERAPEUTICS, INC. | May 24, 2024 | 2 | $0 | 4 | May 29, 2024 | Chief Financial Officer |
RLMD | RELMADA THERAPEUTICS, INC. | Jan 29, 2024 | 3 | $126K | 4 | Jan 31, 2024 | Chief Financial Officer |
RLMD | RELMADA THERAPEUTICS, INC. | Dec 15, 2023 | 1 | $0 | 4 | Dec 19, 2023 | Chief Financial Officer |
RLMD | RELMADA THERAPEUTICS, INC. | May 25, 2023 | 1 | $0 | 4 | May 30, 2023 | Chief Financial Officer |
RLMD | RELMADA THERAPEUTICS, INC. | Dec 16, 2022 | 1 | $0 | 4 | Dec 20, 2022 | CFO |
RLMD | RELMADA THERAPEUTICS, INC. | Dec 16, 2022 | 1 | $0 | 4 | Dec 20, 2022 | Chief Financial Officer |
RLMD | RELMADA THERAPEUTICS, INC. | May 25, 2022 | 2 | $0 | 4 | May 26, 2022 | Chief Financial Officer |
RLMD | RELMADA THERAPEUTICS, INC. | Dec 17, 2021 | 1 | $0 | 4 | Dec 21, 2021 | Chief Financial Officer |